KLBF•IDX•Healthcare•Indonesia•$51.98T

Stocks Similar to KLBF

Top 20 stocks similar to Kalbe Farma Tbk based on sector, industry, market cap, and valuation multiples. Same-industry peers (Drug Manufacturers - General) are ranked first.

Company	Industry	Market Cap	P/E	Yield	Change	Compare
Eli Lilly and Company LLY • United States	Drug Manufacturers - General	$829.71B	40.3	0.66%	-1.32%	vs
Eli Lilly and Company LLY • Switzerland	Drug Manufacturers - General	$822.01B	40.1	0.83%	-4.00%	vs
Johnson & Johnson JNJ • United States	Drug Manufacturers - General	$564.35B	21.2	2.22%	-1.79%	vs
AbbVie Inc 4AB • Germany	Drug Manufacturers - General	$376.87B	88.4	3.76%	-0.20%	vs
AbbVie Inc ABBV • United States	Drug Manufacturers - General	$368.57B	87.6	3.18%	+0.21%	vs
Roche Holding AG ROGN • Mexico	Drug Manufacturers - General	$360.03B	20.7	0.13%	+0.00%	vs
Roche Holding AG RO • Switzerland	Drug Manufacturers - General	$337.77B	20.7	3.01%	+0.97%	vs
Roche Holding AG RHHBF • United States	Drug Manufacturers - General	$331.01B	20.3	2.36%	-0.62%	vs
Roche Holding AG ROG • Switzerland	Drug Manufacturers - General	$327.71B	20.1	3.06%	-6.01%	vs
Roche Holding AG Participation RHHVF • United States	Drug Manufacturers - General	$325.79B	19.7	2.37%	+0.99%	vs
RO Roche Holding AG ROP • Switzerland	Drug Manufacturers - General	$325.37B	20.0	3.13%	+1.39%	vs
AstraZeneca PLC AZN • United States	Drug Manufacturers - General	$317.50B	31.4	1.60%	+0.38%	vs
AstraZeneca PLC AZN • Sweden	Drug Manufacturers - General	$316.82B	30.4	0.17%	-1.58%	vs
AstraZeneca PLC ZEG • Germany	Drug Manufacturers - General	$308.99B	29.0	2.00%	+0.00%	vs
Merck & Company Inc MRK • United States	Drug Manufacturers - General	$294.39B	16.4	2.81%	-1.94%	vs
Novartis AG ADR NVS • United States	Drug Manufacturers - General	$293.34B	21.3	3.12%	-1.35%	vs
AstraZeneca PLC AZNCF • United States	Drug Manufacturers - General	$290.60B	31.1	1.70%	+2.63%	vs
Novartis AG NOVN • Switzerland	Drug Manufacturers - General	$289.75B	21.3	3.97%	-2.87%	vs
MR Merck & Company Inc MRK • Austria	Drug Manufacturers - General	$288.95B	16.1	3.29%	-4.52%	vs
Novartis AG NVSEF • United States	Drug Manufacturers - General	$286.22B	20.9	3.19%	-3.50%	vs

How we rank similar stocks

Similarity is scored by sector match (baseline), industry match (priority boost), log-scale market cap proximity, and valuation multiple closeness (P/E and dividend yield). Same-industry peers surface first, then nearest-size same-sector peers.

View all Healthcare stocks →